V24 HCC 47 (Archived Category) ICD-10-CM
HCC 47 is a payment category of the retired CMS-HCC V24 model, which last determined Medicare Advantage payment in 2025. The 72 ICD-10-CM codes below are its final mappings, kept for lookback analysis and RADV audit reference. Each code shows where it maps in the live V28 model; 34 of them no longer risk-adjust at all.
Archived Codes of V24 HCC 47 72 codes
- D61.810 Antineoplastic chemotherapy induced pancytopenia no V28 successor
- D61.811 Other drug-induced pancytopenia no V28 successor
- D61.818 Other pancytopenia now HCC 109
- D70.0 Congenital agranulocytosis now HCC 115
- D70.1 Agranulocytosis secondary to cancer chemotherapy no V28 successor
- D70.2 Other drug-induced agranulocytosis no V28 successor
- D70.3 Neutropenia due to infection no V28 successor
- D70.4 Cyclic neutropenia now HCC 115
- D70.8 Other neutropenia no V28 successor
- D70.9 Neutropenia, unspecified no V28 successor
- D71 Functional disorders of polymorphonuclear neutrophils now HCC 115
- D72.0 Genetic anomalies of leukocytes now HCC 115
- D76.1 Hemophagocytic lymphohistiocytosis now HCC 115
- D76.2 Hemophagocytic syndrome, infection-associated no V28 successor
- D76.3 Other histiocytosis syndromes now HCC 115
- D80.0 Hereditary hypogammaglobulinemia now HCC 115
- D80.1 Nonfamilial hypogammaglobulinemia no V28 successor
- D80.2 Selective deficiency of immunoglobulin A [IgA] now HCC 115
- D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses now HCC 115
- D80.4 Selective deficiency of immunoglobulin M [IgM] now HCC 115
- D80.5 Immunodeficiency with increased immunoglobulin M [IgM] now HCC 115
- D80.6 Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinemia no V28 successor
- D80.7 Transient hypogammaglobulinemia of infancy no V28 successor
- D80.8 Other immunodeficiencies with predominantly antibody defects no V28 successor
- D80.9 Immunodeficiency with predominantly antibody defects, unspecified no V28 successor
- D81.0 Severe combined immunodeficiency [SCID] with reticular dysgenesis now HCC 114
- D81.1 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers now HCC 114
- D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers now HCC 114
- D81.30 Adenosine deaminase deficiency, unspecified now HCC 114
- D81.31 Severe combined immunodeficiency due to adenosine deaminase deficiency now HCC 114
- D81.32 Adenosine deaminase 2 deficiency now HCC 114
- D81.39 Other adenosine deaminase deficiency now HCC 114
- D81.4 Nezelof's syndrome now HCC 115
- D81.5 Purine nucleoside phosphorylase [PNP] deficiency now HCC 114
- D81.6 Major histocompatibility complex class I deficiency now HCC 114
- D81.7 Major histocompatibility complex class II deficiency now HCC 114
- D81.82 Activated Phosphoinositide 3-kinase Delta Syndrome [APDS] now HCC 114
- D81.89 Other combined immunodeficiencies now HCC 114
- D81.9 Combined immunodeficiency, unspecified now HCC 114
- D82.0 Wiskott-Aldrich syndrome now HCC 115
- D82.1 Di George's syndrome now HCC 115
- D82.2 Immunodeficiency with short-limbed stature no V28 successor
- D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus no V28 successor
- D82.4 Hyperimmunoglobulin E [IgE] syndrome no V28 successor
- D82.8 Immunodeficiency associated with other specified major defects no V28 successor
- D82.9 Immunodeficiency associated with major defect, unspecified no V28 successor
- D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function now HCC 114
- D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders now HCC 114
- D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells now HCC 114
- D83.8 Other common variable immunodeficiencies now HCC 114
- D83.9 Common variable immunodeficiency, unspecified now HCC 114
- D84.0 Lymphocyte function antigen-1 [LFA-1] defect no V28 successor
- D84.81 Immunodeficiency due to conditions classified elsewhere no V28 successor
- D84.821 Immunodeficiency due to drugs no V28 successor
- D84.822 Immunodeficiency due to external causes no V28 successor
- D84.89 Other immunodeficiencies no V28 successor
- D84.9 Immunodeficiency, unspecified no V28 successor
- D89.3 Immune reconstitution syndrome no V28 successor
- D89.40 Mast cell activation, unspecified no V28 successor
- D89.41 Monoclonal mast cell activation syndrome no V28 successor
- D89.42 Idiopathic mast cell activation syndrome no V28 successor
- D89.43 Secondary mast cell activation no V28 successor
- D89.44 Hereditary alpha tryptasemia no V28 successor
- D89.49 Other mast cell activation disorder no V28 successor
- D89.810 Acute graft-versus-host disease now HCC 454
- D89.811 Chronic graft-versus-host disease now HCC 454
- D89.812 Acute on chronic graft-versus-host disease now HCC 454
- D89.813 Graft-versus-host disease, unspecified now HCC 454
- D89.82 Autoimmune lymphoproliferative syndrome [ALPS] no V28 successor
- D89.84 IgG4-related disease now HCC 115
- D89.89 Other specified disorders involving the immune mechanism, not elsewhere classified no V28 successor
- D89.9 Disorder involving the immune mechanism, unspecified no V28 successor
Questions About This Archived Category
Is V24 HCC 47 still paid?
No. The CMS-HCC V24 model last determined Medicare Advantage payment in 2025; from payment year 2026 the V28 model pays 100% of the risk score. This page exists for lookback analysis and RADV audit periods that predate the transition.
Where did these codes go in V28?
Each row above names the code's live V28 category, or marks it as having no V28 successor. The category-level picture, with destination counts for every V24 category, is on V24 to V28: What Changed.
Related References
Source: Centers for Medicare & Medicaid Services, Payment Year 2026 risk adjustment mapping and model software releases (CMS-HCC V28; CMS-HCC V24 from the last published V24 mappings, payment year 2025), applied to the FY 2026 ICD-10-CM code set. ICD List is not affiliated with CMS.
